You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

LIQUAEMIN SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Liquaemin Sodium, and what generic alternatives are available?

Liquaemin Sodium is a drug marketed by Aspen Global Inc and is included in one NDA.

The generic ingredient in LIQUAEMIN SODIUM is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Liquaemin Sodium

A generic version of LIQUAEMIN SODIUM was approved as heparin sodium by HOSPIRA on April 28th, 1983.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LIQUAEMIN SODIUM?
  • What are the global sales for LIQUAEMIN SODIUM?
  • What is Average Wholesale Price for LIQUAEMIN SODIUM?
Summary for LIQUAEMIN SODIUM
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:LIQUAEMIN SODIUM at DailyMed
Drug patent expirations by year for LIQUAEMIN SODIUM

US Patents and Regulatory Information for LIQUAEMIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aspen Global Inc LIQUAEMIN SODIUM heparin sodium INJECTABLE;INJECTION 000552-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Aspen Global Inc LIQUAEMIN SODIUM PRESERVATIVE FREE heparin sodium INJECTABLE;INJECTION 000552-012 Apr 11, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Aspen Global Inc LIQUAEMIN SODIUM heparin sodium INJECTABLE;INJECTION 000552-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Aspen Global Inc LIQUAEMIN SODIUM PRESERVATIVE FREE heparin sodium INJECTABLE;INJECTION 000552-013 Apr 11, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Aspen Global Inc LIQUAEMIN SODIUM heparin sodium INJECTABLE;INJECTION 000552-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Aspen Global Inc LIQUAEMIN SODIUM heparin sodium INJECTABLE;INJECTION 000552-005 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Aspen Global Inc LIQUAEMIN SODIUM PRESERVATIVE FREE heparin sodium INJECTABLE;INJECTION 000552-011 Apr 11, 1986 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.